Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Pulsed Dye Laser effectively treats skin lesions in Rosai–Dorfman Disease.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Clofazimine effectively treated ashy dermatosis in a patient.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Fractional Er:YAG laser with PRP is more effective and has fewer side effects than microneedling with PRP for vitiligo.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Adalimumab helped control a child's severe eye disease when other treatments failed.